BCOR Biology in Development and Cancer
- 1Center for Molecular Medicine, University of Georgia, Athens, GA 30602, USA.
- 2Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Abstract
BCOR is a transcriptional corepressor and a core component of Polycomb repressive complex 1.1 (PRC1.1) with diverse roles in development and disease. Germline loss-of-function BCOR mutations cause oculofaciocardiodental syndrome, whereas diverse somatic alterations drive various malignancies. In myeloid neoplasms, loss-of-function truncating mutations disrupt BCOR-mediated transcriptional repression and cooperate with concurrent oncogenic events. Meanwhile, BCOR fusions and internal tandem duplications define distinct tumor entities in sarcomas and brain tumors. Growing evidence indicates that these somatic alterations are not mechanistically equivalent and that the functional impact of BCOR alterations is highly context-dependent, varying across cell types and developmental stages. How these distinct mutations disrupt molecular programs to drive oncogenesis remains a central question in the field. This review summarizes the current knowledge of BCOR domain organization, its epigenetic and physiological functions, and the emerging mutational landscape in human malignancies.
Related
- Exosomes in Cancer: The Biology, Function, Diagnosis, and Therapy.
- Systems-Level Decoding of Redox Homeostasis in Cancer: From ROS Biology to Therapeutic Vulnerabilities
- Beyond Structural Classification: A 4S+G Functional Framework for Non-Coding RNA Biology in Cancer and Its Therapeutic Implications
- Multi-lineage reprogramming and NOTCH-associated signaling remodeling characterize the aggressive biology of early-onset colorectal cancer
- Development and initial evaluation of a urine DNA methylation assay for pan-urinary cancer detection
BibTeX
@article{royston2026bcor,
title = {{BCOR Biology in Development and Cancer}},
author = {Hitomi N Royston and Alberto Taddia and Fabio R Santori and Natalia Ivanova and Kosuke Funato},
journal = {Cells},
year = {2026},
month = oct,
doi = {10.3390/cells15201856},
url = {https://www.mdpi.com/2073-4409/15/20/1856},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - BCOR Biology in Development and Cancer
AU - Hitomi N Royston
AU - Alberto Taddia
AU - Fabio R Santori
AU - Natalia Ivanova
AU - Kosuke Funato
PY - 2026
DA - 2026/10/13
JO - Cells
DO - 10.3390/cells15201856
UR - https://www.mdpi.com/2073-4409/15/20/1856
AB - BCOR is a transcriptional corepressor and a core component of Polycomb repressive complex 1.1 (PRC1.1) with diverse roles in development and disease. Germline loss-of-function BCOR mutations cause oculofaciocardiodental syndrome, whereas diverse somatic alterations drive various malignancies. In myeloid neoplasms, loss-of-function truncating mutations disrupt BCOR-mediated transcriptional repression and cooperate with concurrent oncogenic events. Meanwhile, BCOR fusions and internal tandem duplications define distinct tumor entities in sarcomas and brain tumors. Growing evidence indicates that these somatic alterations are not mechanistically equivalent and that the functional impact of BCOR alterations is highly context-dependent, varying across cell types and developmental stages. How these distinct mutations disrupt molecular programs to drive oncogenesis remains a central question in the field. This review summarizes the current knowledge of BCOR domain organization, its epigenetic and physiological functions, and the emerging mutational landscape in human malignancies.
SN - 2073-4409
ER -